|
|
| Research article summary (published 15 Sep 2009): |
Good law from tragic facts--Congress, the FDA, and preemption.
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Annas, George J (GJ);
Affiliation: Department of Health Law, Bioethics, and Human Rights, Boston University School of Public Health, Boston, USA.
Journal and publication information
Publication Type: Journal Article
Journal: The New England journal of medicine (N Engl J Med), published in United States. (Language: eng)
Reference: 2009-Sep; vol 361 (issue 12) : pp 1206-11
Dates: Created 2009/09/17; Completed 2009/09/23;
PMID: 19759383, status: MEDLINE (last retrieval date: 9/23/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
29 Jun 2008 - The Supreme Court, preemption, and malpractice liability.
3 Feb 2009 - The federal preemption debate in pharmaceutical labeling product liability actions.
30 Dec 2006 - Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
29 Sep 2008 - Warning signs.
18 Mar 2008 - FDA targets unapproved drugs.
13 Feb 2007 - Pros and cons of off-label promotion investigations and prosecutions.
30 Dec 2005 - The FDA: is it protecting the public with one hand tied behind its back?
30 Dec 1991 - Bolstering the FDA's drug-safety authority.
27 Nov 2007 - Bush tails follow-ons.
30 Mar 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.